Characterization of the First Carbapenem-Resistant Pseudomonas aeruginosa Clinical Isolate Harboring blaSIM-1 from the United States

Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0106621. doi: 10.1128/AAC.01066-21. Epub 2021 Aug 2.
No abstract available

Keywords: Pseudomonas aeruginosa; antibiotic resistance; beta-lactamases; carbapenems; genome analysis; long-read sequencing.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins
  • Carbapenems / pharmacology
  • Humans
  • Microbial Sensitivity Tests
  • Pseudomonas Infections* / drug therapy
  • Pseudomonas aeruginosa* / genetics
  • United States
  • beta-Lactamases / genetics

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Carbapenems
  • beta-Lactamases